Kevin Ariën

Research output

Research output per year 2005 2021 2022 2023 2024

• 128 A1: Web of Science-article
• 12 Conference abstract in journal
• 9 Letter
• 3 Comment/debate
• 6 More
  • 2 Editorial
  • 2 Review
  • 1 A2: International peer reviewed article (not A1-type)
  • 1 Doctoral dissertation - Doctoral dissertation

Research output per year

Research output per year

Search results

• A1: Web of Science-article

  Host factors and pathways involved in the entry of mosquito-borne alphaviruses

  De Caluwé, L., Ariën, K. K. & Bartholomeeusen, K., 2021, In: Trends in Microbiology. 29, 7, p. 634-647 14 p., 1893.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Chikungunya virus 100%
  • Tropism 21%
  • Viruses 11%
  • Infections 8%

• Human Immunodeficiency Virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides

  Selhorst, P., Vazquez, AC., Terrazas-Aranda, K., Michiels, J., Vereecken, K., Heyndrickx, L., Weber, J., Quiñones-Mateu, ME., Ariën, KK. & Vanham, G., 2011, In: Antimicrobial Agents and Chemotherapy. 55, 4, p. 1403-1413 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  File

  • Reverse Transcriptase Inhibitors 100%
  • HIV-1 72%
  • UC 781 53%
  • Nevirapine 24%
  • Viruses 24%
  42 Downloads (Pure)

• Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients

  Kemlin, D., Gemander, N., Depickère, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. E., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Ariën, K. K., Matagne, A., Ackerman, M. E., Le Moine, A. & Marchant, A., 2023, In: American Journal of Transplantation. 23, 5, p. 649-658 10 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Kidney 36%
  • Infections 32%
  • Interferon-gamma 30%
  • Vulnerable Populations 17%
  26 Downloads (Pure)

• Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients

  Debie, Y., Van Audenaerde, J. R. M., Vandamme, T., Croes, L., Teuwen, L-A., Verbruggen, L., Vanhoutte, G., Marcq, E., Verheggen, L., Le Blon, D., Peeters, B., Goossens, M. E., Pannus, P., Ariën, K. K., Anguille, S., Janssens, A., Prenen, H., Smits, E. L. J., Vulsteke, C., Lion, E., & 2 othersPeeters, M. & van Dam, P. A., 2022, In: Clinical Cancer Research. 29, 3, p. 635–646 12 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • anti-IgG 25%
  • Neoplasms 21%
  • Peptides 7%
  11 Downloads (Pure)

• Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial

  Steenackers, K., Hanning, N., Bruckers, L., Desombere, I., Marchant, A., Ariën, K., Georges, D., Soentjens, P., D'Onofrio, V., Hites, M., Berens-Riha, N., De Coster, I. & Van Damme, P., 2024, In: Vaccine. 42, 25, 12 p., 126117.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

• Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination

  De Bouver, C., Bouziotis, J., Wijtvliet, VPWM., Ariën, KK., Mariën, J., Heyndrickx, L., Couttenye, MM., de Fijter, HJW., Mestrez, F., Treille, S., Mat, O., Collart, F., Allard, SD., Vingerhoets, L., Moons, P., Abramowicz, D., De Winter, BY., Pipeleers, L., Wissing, KM. & Ledeganck, KJ., 2024, In: Virology Journal. 21, 1, 14 p., 138.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • SARS Virus 100%
  • Kidney 36%
  • Infections 32%
  • Seroconversion 17%
  • Multicenter Studies 6%

• Hybrid immunity overcomes defective immune response to COVID-19 vaccination in kidney transplant recipients

  Gemander, N., Kemlin, D., Depickère, S., Kelkar, NS., Pannus, P., Sharma, S., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Vandevenne, M., Goossens, ME., Matagne, A., Desombere, I., Ariën, KK., & 3 othersAckerman, ME., Le Moine, A. & Marchant, A., 2024, In: Kidney International Reports. 9, 3, p. 635-648 14 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • SARS Virus 100%
  • Kidney 58%
  • Mycophenolic Acid 15%
  • Kidney Transplantation 12%
  • Immunosuppressive Agents 11%

• Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function

  Meuwissen, P. J., Stolp, B., Iannucci, V., Vermeire, J., Naessens, E., Saksela, K., Geyer, M., Vanham, G., Ariën, K. K., Fackler, O. T. & Verhasselt, B., 2012, In: Retrovirology. 9, 34, p. 1-18 18 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Valine 100%
  • Glycine 85%
  • HIV-1 73%
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) 66%
  • Amino Acids 58%
  26 Downloads (Pure)

• Immunogenicity and protection efficacy of a naked self-replicating mRNA-based Zika virus vaccine

  Zhong, Z., Portela Catani, J. P., Mc Cafferty, S., Couck, L., Van Den Broeck, W., Gorlé, N., Vandenbroucke, R. E., Devriendt, B., Ulbert, S., Cnops, L., Michels, J., Ariën, K. K. & Sanders, N. N., 2019, In: Vaccines. 7, 3, 17 p., 96.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Messenger RNA 100%
  • Zika Virus 99%
  • Intradermal 81%
  • Electroporation 71%
  • Glycoprotein 23%
  72 Downloads (Pure)

• Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme

  Moerman, A., Vernelen, K., China, B., Capron, A., Van Den Bossche, D., Mariën, J., Ariën, K. K., Van Acker, J., Delforge, M-L., Reynders, M., Boel, A., Depypere, M., Van Gasse, N., Vijgen, S., Brauner, J., Dujardin, B. & Padalko, E., 2022, In: Diagnostic Microbiology and Infectious Disease. 102, 2, 6 p., 115561.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • SARS Virus 100%
  • Infections 10%
  • Serum 10%

• Inactivation of SARS-CoV-2 and other enveloped and non-enveloped viruses with non-thermal plasma for hospital disinfection

  Sahun, M., Privat-Maldonado, A., Lin, A., De Roeck, N., Van der Heyden, L., Hillen, M., Michiels, J., Steenackers, G., Smits, E., Ariën, K. K., Jorens, P. G., Delputte, P. & Bogaerts, A., 2023, In: ACS sustainable chemistry & engineering. 11, 13, p. 5206-5215 10 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Disinfection 94%
  • Viruses 76%
  • disinfection 63%
  • hospital 62%
  • Plasmas 59%
  100 Downloads (Pure)

• Inhibition of HIV virus by neutralizing Vhh attached to dual functional liposomes encapsulating dapivirine

  Wang, S. X., Michiels, J., Ariën, K. K., New, R., Vanham, G. & Roitt, I., 2016, In: Nanoscale Research Letters. 11, p. 350

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Liposomes 100%
  • Antibodies 77%
  • Viruses 71%
  • Liposome 56%
  • Neutralization 17%
  44 Downloads (Pure)

• Insights from early clinical trials assessing response to mRNA SARS-CoV-2 vaccination in immunocompromised patients

  Baron, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., Beguin, Y., Marchant, A. & Humblet-Baron, S., 2022, In: Frontiers in Immunology. 13, 18 p., 827242.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Janus Kinase Inhibitors 15%
  • Immunosuppressive Agents 9%
  • Immune System 8%
  24 Downloads (Pure)

• Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with the HIV-1 surface protein

  Morellato-Castillo, L., Acharya, P., Combes, O., Michiels, J., Descours, A., Ramos, O. H., Yang, Y., Vanham, G., Ariën, K. K., Kwong, P. D., Martin, L. & Kessler, P., 2013, In: J Med Chem. 56, 12, p. 5033-5047 15 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • HIV-1 100%
  • Molecular Cluster 74%
  • 4-aminophenylalanine 64%
  • Phenylalanine Derivative 59%
  • Phenylalanine Residue 53%

• In vitro activity of candidate microbicides against cell-associated HIV

  Selhorst, P., Grupping, K., Bourlet, T., Delezay, O., Ariën, KK. & Vanham, G., 2012, In: Antimicrobial Agents and Chemotherapy. 56, 2, p. 805-815

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  File

  • Coculture Techniques 100%
  • Cell Line 89%
  • CCR5 Receptors 74%
  • Infections 71%
  • Reporter Genes 49%
  36 Downloads (Pure)

• In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine

  das Neves, J., Araujo, F., Andrade, F., Michiels, J., Ariën, K. K., Vanham, G., Amiji, M., Bahia, M. F. & Sarmento, B., 2013, In: Molecular Pharmaceutics. 10, 7, p. 2793-2807 15 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Dapivirine 100%
  • Rectal 80%
  • Anti Human Immunodeficiency Virus Agent 79%
  • Nanoparticle 27%
  • Drug 22%

• In vitro evaluation of viability, integrity and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides

  Gali, Y., Delezay, O., Brouwers, J., Addad, N., Augustijns, P., Bourlet, T., Hamzeh-Cognasse, H., Ariën, KK., Pozzetto, B. & Vanham, G., 2010, In: Antimicrobial Agents and Chemotherapy. 54, 12, p. 5105-5114 10 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Genitalia 100%
  • UC 781 83%
  • Epithelium 82%
  • Pharmaceutical Preparations 44%
  • Interleukin-8 41%

• Is HIV-1 evolving to a less virulent form in humans? [opinion]

  Ariën, KK., Vanham, G. & Arts, EJ., 2007, In: Nature Reviews Microbiology. 5, 2, p. 141-151

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Japanese encephalitis in a young traveler returning from a short-term holiday in Khao Lak, Thailand

  Huits, R., Eelen, Y., Jorens, P. G., Ariën, K. K., Van Esbroeck, M. & Duval, E. L., 2020, In: Travel Medicine and Infectious Disease. 34, 2 p., 101580.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding

  Selhorst, P., Grupping, K., Tong, T., Crooks, E. T., Martin, L., Vanham, G., Binley, J. M. & Ariën, K. K., 2013, In: Retrovirology. 10, 12, p. 1-9 9 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Virion 100%
  • HIV-1 91%
  • Viruses 69%
  • Epithelium 39%
  • Amino Acids 36%
  53 Downloads (Pure)

• Mayaro virus, a potential threat for Europe: vector competence of autochthonous vector species

  Brustolin, M., Bartholomeeusen, K., Teodoro Rezende, T., Ariën, KK. & Müller, R., 2024, In: Parasites and Vectors. 17, 9 p., 200.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • Mental Competency 100%
  • Aedes 86%
  • Viruses 69%
  • Italy 65%
  • Laboratory Infection 51%

• MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency

  Grupping, K., Selhorst, P., Michiels, J., Vereecken, K., Heyndrickx, L., Kessler, P., Vanham, G., Martin, L. & Ariën, K. K., 2012, In: Retrovirology. 9, 36, p. 1-16 16 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • HIV-1 100%
  • Viruses 28%
  • CD4 Antigens 18%
  • Clone Cells 11%
  56 Downloads (Pure)

• Molecular characterization of chikungunya virus during the 2019 outbreak in the Democratic Republic of the Congo

  Selhorst, P., Makiala-Mandanda, S., Smet, B. D., Mariën, J., Anthony, C., Binene-Mbuka, G., Weggheleire, A. D., Ilombe, G., Kinganda-Lusamaki, E., Pukuta-Simbu, E., Lubula, L., Mbala-Kingebeni, P., Nkuba-Ndaye, A., Vogt, F., Watsenga, F., Bortel, W. V., Vanlerberghe, V., Ariën, K. K. & Ahuka-Mundeke, S., 2020, In: Emerging Microbes & Infections. 9, 1, p. 1912-1918 7 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Chikungunya virus 100%
  • Democratic Republic of the Congo 97%
  • Aedes 66%
  • Strain 33%
  • mosquito-borne diseases 26%
  36 Downloads (Pure)

• mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

  Wijtvliet, V. P. W. M., Ariën, K. K., Abrams, S., Couttenye, M. M., Mestrez, F., Mariën, J., De Winter, B. Y., Van Damme, P., Pipeleers, L., Wissing, K. M., Abramowicz, D. & Ledeganck, K. J., 2022, In: Nephrology, Dialysis, Transplantation. 37, 4, p. 799-803 5 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File
  31 Downloads (Pure)

• Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo

  Raulino, R., Thaurignac, G., Butel, C., Villabona-Arenas, C. J., Foe, T., Loul, S., Ndimbo-Kumugo, S-P., Mbala-Kingebeni, P., Makiala-Mandanda, S., Ahuka-Mundeke, S., Kerkhof, K., Delaporte, E., Ariën, K. K., Foulongne, V., Mpoudi Ngole, E., Peeters, M. & Ayouba, A., 2021, In: PLoS Neglected Tropical Diseases. 15, 1, 20 p., e0009028.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Democratic Republic of the Congo 100%
  • West Nile virus 95%
  • Cameroon 87%
  • Yellow Fever 59%
  • Central Africa 24%
  44 Downloads (Pure)

• Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) [letter]

  Venkatraj, M., Ariën, KK., Heeres, J., Dirié, B., Joossens, J., Van Goethem, S., Van der Veken, P., Michiels, J., Vande Velde, CML., Vanham, G., Lewi, PJ. & Augustyns, K., 2011, In: Bioorganic and Medicinal Chemistry. 19, 20, p. 5924-5934 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Nonnucleoside Reverse Transcriptase Inhibitor 100%
  • Human immunodeficiency virus 1 reverse transcriptase 95%
  • Reverse Transcriptase Inhibitors 83%
  • HIV-1 60%
  • Strain 48%

• nsP4 is a major determinant of alphavirus replicase activity and template selectivity

  Lello, L. S., Bartholomeeusen, K., Wang, S., Coppens, S., Fragkoudis, R., Alphey, L., Ariën, K. K., Merits, A. & Utt, A., 2021, In: Journal of Virology. 95, 20, 65 p., e0035521.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Open Reading Frames 100%
  • Viruses 92%
  • Venezuelan Equine Encephalitis Viruses 54%
  • Chikungunya virus 48%
  • Virus Replication 34%
  41 Downloads (Pure)

• Peptide biomarkers for the diagnosis of dengue infection

  Falconi-Agapito, F., Kerkhof, K., Merino, X., Bakokimi, D., Torres, F., Van Esbroeck, M., Talledo, M. & Ariën, K. K., 2022, In: Frontiers in Immunology. 13, 14 p., 793882.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Dengue Virus 100%
  • Peptides 53%
  • Infections 40%
  • Yellow fever virus 17%
  • Virus Diseases 8%
  49 Downloads (Pure)

• Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients

  Etienne, I., Kemlin, D., Gemander, N., Olislagers, V., Waegemans, A., Dhondt, E., Heyndrickx, L., Depickere, S., Charles, A., Goossens, M., Vandermosten, L., Desombere, I., Arien, KK., Pannus, P., Knoop, C. & Marchant, A., 2024, In: Journal of Heart and Lung Transplantation. 43, 11, p. 1857-1860 4 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

• Phylogeographic analysis of dengue virus serotype 1 and cosmopolitan serotype 2 in Africa

  Selhorst, P., Lequime, S., Dudas, G., Proesmans, S., Lutumba, P., Katshongo, F., Ramadan, K., Micalessi, I., Ahuka-Mundeke, S., Vanlerberghe, V., Van Esbroeck, M. & Ariën, K. K., 2023, In: International Journal of Infectious Diseases. 133, p. 46-52 7 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Dengue Virus 100%
  • Serogroup 76%
  • Democratic Republic of the Congo 34%
  • Watchful Waiting 9%
  • History 6%
  12 Downloads (Pure)

• Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine

  das Neves, J., Michiels, J., Ariën, K. K., Vanham, G., Amiji, M., Bahia, M. F. & Sarmento, B., 2012, In: Pharmaceutical Research. 29, 6, p. 1468-1484 17 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Dapivirine 100%
  • Antiretroviral 77%
  • Antimicrobial Agent 38%
  • Drug 28%
  • Nanoparticle 27%

• Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes

  Pannus, P., Neven, K. Y., De Craeye, S., Heyndrickx, L., Vande Kerckhove, S., Georges, D., Michiels, J., Francotte, A., Van Den Bulcke, M., Zrein, M., Van Gucht, S., Schmickler, M-N., Verbrugghe, M., Matagne, A., Thomas, I., Dierick, K., Weiner, J. A., Ackerman, M. E., Goriely, S., Goossens, M. E., & 3 othersAriën, K. K., Desombere, I. & Marchant, A., 2021, (E-pub ahead of print) In: Clinical Infectious Diseases. 75, 1, p. e695–e704 10 p., ciab998.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Infections 10%
  22 Downloads (Pure)

• Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study

  De Vos, E., Van Gestel, L., Brosius, I., Kenyon, C., Vuylsteke, B., De Baetselier, I., Mariën, J., Bangwen, E., Couvreur, S., Lecompte, A., Van Beckhoven, D., Hoorelbeke, B., Verstrepen, BE., Zaeck, LM., de Vries, RD., van Kessel, CHG., Hens, N., Ariën, KK., Vercauteren, K., Van Esbroek, M., & 2 othersVan Dijck, C. & Liesenborghs, L., 2024, In: International Journal of Infectious Diseases. 146, 9 p., 107132.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

• Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors

  Konnova, A., De Winter, F. H. R., Gupta, A., Verbruggen, L., Hotterbeekx, A., Berkell, M., Teuwen, L-A., Vanhoutte, G., Peeters, B., Raats, S., der Massen, I. V., De Keersmaecker, S., Debie, Y., Huizing, M., Pannus, P., Neven, K. Y., Ariën, K., Martens, G. A., Bulcke, M. V. D., Roelant, E., & 11 othersDesombere, I., Anguille, S., Berneman, Z., Goossens, M. E., Goossens, H., Malhotra-Kumar, S., Tacconelli, E., Vandamme, T., Peeters, M., van Dam, P. & Kumar-Singh, S., 2022, In: Frontiers in Immunology. 13, 10 p., 1062136.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Neoplasms 100%
  • SARS Virus 65%
  • Vaccine Immunogenicity 62%
  • Interleukin-15 56%
  • Constitution and Bylaws 54%
  11 Downloads (Pure)

• Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients

  Canti, L., Humblet-Baron, S., Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., Servais, S., Willems, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A. & Baron, F., 2021, In: Journal of Hematology & Oncology. 14, 1, 12 p., 174.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Flow Cytometry 10%
  • Infections 6%
  13 Downloads (Pure)

• Presymptomatic viral shedding in high-risk contacts of monkeypox cases: a prospective cohort study

  ITM Monkeypox Study Group, 2023, In: Journal of Medical Virology. 95, 5, e28769.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Virus Shedding 100%
  • Viruses 49%
  • Polymerase Chain Reaction 29%
  • Viral DNA 27%
  • Diaries 26%
  37 Downloads (Pure)

• Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study

  Mortgat, L., Verdonck, K., Hutse, V., Thomas, I., Barbezange, C., Heyndrickx, L., Fischer, N., Vuylsteke, B., Kabouche, I., Ariën, K. K., Desombere, I. & Duysburgh, E., 2021, In: BMJ Open. 11, 6, 10 p., e050824.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Health Personnel 58%
  • Incidence 32%
  • Neutralization Tests 25%
  • Seroconversion 10%
  21 Downloads (Pure)

• Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanisms

  Van Nuffel, A., Ariën, K. K., Stove, V., Schindler, M., O'Neill, E., Schmökel, J., Van de Walle, I., Naessens, E., Vanderstraeten, H., Van Landeghem, K., Taghon, T., Pulkkinen, K., Saksela, K., Garcia, J. V., Fackler, O. T., Kirchhoff, F. & Verhasselt, B., 2013, In: Retrovirology. 10, 137

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • HIV-1 100%
  • HIV-2 49%
  • Thymocytes 41%
  • nef Genes 31%
  • Viral Load 18%
  55 Downloads (Pure)

• Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium

  Mariën, J., Ceulemans, A., Bakokimi, D., Lammens, C., Ieven, M., Heytens, S., De Sutter, A., Verbakel, J. Y., Van den Bruel, A., Goossens, H., Van Damme, P., Ariën, K. K. & Coenen, S., 2021, (E-pub ahead of print) In: Family Practice. p. 92-98 7 p., cmab094.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Health Personnel 58%
  • Occupational Groups 13%
  • Delivery of Health Care 11%
  • Immunoassay 9%
  22 Downloads (Pure)

• Randomized, double-blind, placebo-controlled trial of a throat spray with selected Lactobacilli in COVID-19 outpatients

  De Boeck, I., Cauwenberghs, E., Spacova, I., Gehrmann, T., Eilers, T., Delanghe, L., Wittouck, S., Bron, P. A., Henkens, T., Gamgami, I., Simons, A., Claes, I., Mariën, J., Ariën, K. K., Bakokimi, D., Loens, K., Jacobs, K., Ieven, M., Bruijning-Verhagen, P., Delputte, P., & 3 othersCoenen, S., Verhoeven, V. & Lebeer, S., 2022, In: Microbiology Spectrum. 10, 5, p. e0168222 14 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • spray 79%
  • trial 65%
  • Outpatients 61%
  • Placebos 56%
  • Severe Acute Respiratory Syndrome 52%
  14 Downloads (Pure)

• Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment

  Peeters, M., Verbruggen, L., Teuwen, L., Vanhoutte, G., Vande Kerckhove, S., Peeters, B., Raats, S., Van der Massen, I., De Keersmaecker, S., Debie, Y., Huizing, M., Pannus, P., Neven, K., Ariën, K. K., Martens, G. A., Van Den Bulcke, M., Roelant, E., Desombere, I., Anguille, S., Goossens, M., & 2 othersVandamme, T. & van Dam, P., 2021, In: ESMO Open. 6, 5, 11 p., 100274.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Severe Acute Respiratory Syndrome 100%
  • Neoplasms 81%
  • Confidence Intervals 46%
  • coronavirus receptor 35%
  • Hematology 20%
  9 Downloads (Pure)

• Reliable serological diagnostic tests for arboviruses: feasible or utopia?

  Kerkhof, K., Falconi-Agapito, F., Van Esbroeck, M., Talledo, M. & Ariën, K. K., 2020, In: Trends in Microbiology. 28, 4, p. 276-292 17 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Utopias 100%
  • Routine Diagnostic Tests 51%
  • Air Travel 21%
  • Infections 13%

• Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones

  Ariën, KK., Gali, Y., El-Abdellati, A., Heyndrickx, L., Janssens, W. & Vanham, G., 2006, In: Virology. 347, 1, p. 65-74

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time

  Ariën, KK., Troyer, RM., Gali, Y., Colebunders, R., Arts, EJ. & Vanham, G., 2005, In: AIDS. 19, 15, p. 1555-1564

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398

  Ariën, K. K., Venkatraj, M., Michiels, J., Joossens, J., Vereecken, K., Van der Veken, P., Heeres, J., De Winter, H., Heyndrickx, L., Augustyns, K. & Vanham, G., 2016, In: Journal of Antimicrobial Chemotherapy. 71, 5, p. 1159-1168

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • Dapivirine 100%
  • Reverse Transcriptase Inhibitors 65%
  • Viruses 36%

• Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium

  ITM Monkeypox Study Group, 2022, In: Nature Medicine. 28, 11, p. 2288-2292 5 p., 1081.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Monkeypox virus 100%
  • Sampling 48%
  • Virus Diseases 43%
  • Time 21%
  • Gonorrhea 11%
  37 Downloads (Pure)

• Reverse transcriptase inhibitors as microbicides

  Lewi, P., Heeres, J., Ariën, K., Venkatraj, M., Joossens, J., Van der Veken, P., Augustyns, K. & Vanham, G., 2012, In: Current HIV Research. 10, 1, p. 27-35

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Reverse Transcriptase Inhibitors 100%
  • Dapivirine 50%
  • UC 781 26%
  • Urea 13%
  • HIV-1 12%

• Rho GTPase Cdc42 is essential for human T-cell development

  Smits, K., Iannucci, V., Stove, V., Van Hauwe, P., Naessens, E., Meuwissen, P. J., Ariën, K., Bentahir, M., Plum, J. & Verhasselt, B., Mar-2010, In: Acta Haematologica. 95, 3, p. 367-75 9 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Thymocytes 100%
  • Organ Culture Techniques 72%
  • GTP Phosphohydrolases 35%
  • Kinetics 22%
  • Apoptosis 18%
  22 Downloads (Pure)

• Role of wildlife in emergence of Ebola virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017

  Gryseels, S., Mbala-Kingebeni, P., Akonda, I., Angoyo, R., Ayouba, A., Baelo, P., Mukadi, D. B., Bugentho, E., Bushmaker, T., Butel, C., Calvignac-Spencer, S., Delaporte, E., De Smet, B., Düx, A., Edidi-Atani, F., Fischer, R., Kahandi, C., Kapetshi, J., Sumba, S. K., Kouadio, L., & 25 othersBendeke, A. M., Mande, C., Sepolo, G. M., Moudindo, J., Ngole, E. M., Musaba, P., Mutombo, P., Bass, I. N., Nebesse, C., Ngoy, S., Kumogo, S-P. N., Seifert, S. N., Tanzito, J., Akaibe, D., Amundala, N., Ariën, K. K., Gembu, G-C., Leendertz, F. H., Leirs, H., Mukinzi, J-C., Munster, V., Muyembe-Tamfum, J-J., Peeters, M., Verheyen, E. & Ahuka-Mundeke, S., 2020, In: Emerging Infectious Diseases. 26, 9, p. 2205-2209 5 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Democratic Republic of the Congo 100%
  • Ebolavirus 99%
  • Infections 8%
  36 Downloads (Pure)

• Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): a single blind, randomized, non-inferiority trial

  Pannus, P., Depickère, S., Kemlin, D., Houben, S., Neven, K. Y., Heyndrickx, L., Michiels, J., Willems, E., De Craeye, S., Francotte, A., Chaumont, F., Olislagers, V., Waegemans, A., Verbrugghe, M., Schmickler, M-N., Van Gucht, S., Dierick, K., Marchant, A., Desombere, I., Ariën, K. K., & 1 othersGoossens, M. E., 2022, In: PLoS Global Public Health. 2, 12, p. e0001308 17 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • anti-IgG 100%
  • Income 73%
  • Infections 21%
  24 Downloads (Pure)